Improving Paediatric R&D Success: Integrating The Younger Patient And Caregiver's Perspective Into Trial Design
By Michael Armstrong, MD, Ph.D., senior medical director of Oncology at IQVIA Biotech; Charlie Fix, global director of Scientific Harmonization at Q2 Solutions; and Eric Neeley, Ph.D., PMP, senior director of Research Nursing & Phlebotomy Solutions at IQVIA

When embarking on pediatric trials, sponsors must meticulously craft a comprehensive strategy early in the design phase, considering the myriad nuances inherent in such endeavors. IQVIA's Eric Neeley, IQVIA Biotech's Michael Armstrong, and Q2 Solutions' Charlie Fix offer invaluable insights into key considerations for enhancing pediatric clinical trials.
Delving into topics ranging from facilitating at-home trial participation to ensuring safe blood collection and fostering collaborative cancer care, these experts underscore the importance of integrating pediatric patient and caregiver perspectives into the trial design process to optimize outcomes and uphold ethical standards.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.